CS
The startup develops biopharmaceutical therapies and detection technologies to protect against chemical and biological weapons threats. Its solutions provide soldiers and first responders with effective decontamination and medical countermeasures, enhancing safety in tactical and emergency situations.
Updated 3 months ago
Funding
$4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops biopharmaceutical therapies and detection technologies to protect against chemical and biological weapons threats. Its solutions provide soldiers and first responders with effective decontamination and medical countermeasures, enhancing safety in tactical and emergency situations.